NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 430 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386 | -2.0% | 53,195 | +0.4% | 0.00% | – |
| Q2 2023 | $394 | -1.7% | 52,993 | -8.4% | 0.00% | – |
| Q1 2023 | $401 | -15.4% | 57,831 | +25.3% | 0.00% | – |
| Q4 2022 | $474 | -99.9% | 46,138 | +1.2% | 0.00% | – |
| Q3 2022 | $830,000 | -62.6% | 45,583 | +5.7% | 0.00% | – |
| Q2 2022 | $2,217,000 | -32.0% | 43,110 | -2.6% | 0.00% | – |
| Q1 2022 | $3,261,000 | -89.5% | 44,277 | -79.6% | 0.00% | -100.0% |
| Q4 2021 | $31,097,000 | -67.8% | 217,357 | -53.3% | 0.00% | -66.7% |
| Q3 2021 | $96,590,000 | +16.7% | 465,919 | +19.6% | 0.01% | +12.5% |
| Q2 2021 | $82,742,000 | -44.5% | 389,724 | -52.6% | 0.01% | -46.7% |
| Q1 2021 | $149,176,000 | +286.6% | 822,768 | +137.8% | 0.02% | +275.0% |
| Q4 2020 | $38,584,000 | +86.3% | 346,018 | +81.0% | 0.00% | +100.0% |
| Q3 2020 | $20,712,000 | +8.7% | 191,160 | -16.4% | 0.00% | 0.0% |
| Q2 2020 | $19,062,000 | – | 228,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |